Preclinical differentiation of low molecular weight heparins.
Nader
H B
HB
Departmenta de Bioquimica, Escola Paulista de Medicina, São Paulo, Brazil.
Walenga
J M
JM
Berkowitz
S D
SD
Ofosu
F
F
Hoppensteadt
D A
DA
Cella
G
G
D000818:Animals; D001682:Biological Availability; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight / Q000737:chemistry* / Q000493:pharmacokinetics / Q000592:standards; D006801:Humans; D011516:Prothrombin / Q000037:antagonists & inhibitors; D013329:Structure-Activity Relationship; D013917:Thrombin / Q000187:drug effects
D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight; D011516:Prothrombin; C025337:Factor IIa; D013917:Thrombin